21.07.2011 • News • AkzoNobel • Q2 2011 • sales and profits

AkzoNobel Q2 Profit Flat

AkzoNobel reported that its second-quarter profit from continuing operations was almost flat at €273 million. Earnings per share from continuing operations were €1.07 compared to €1.05 in the previous year quarter.

Net income for the period was €268 million, lower than €273 million in the prior year quarter. Earnings per share from total operations decreased to €1.14 from €1.16 in the same quarter last year.

Adjusted net income for continuing operations was €256 million, compared to €275 million in the same period last year. Adjusted earnings per share for the quarter were 1.09, down from €1.18 in the previous year quarter.

Quarterly revenue rose 5% to €4.1 billion from €3.91 billion last year, driven by volume and price.

Looking ahead, Akzo Nobel expects full-year EBITDA to be at least in line with the prior year, assuming no further deterioration in economic conditions.

Company

AkzoNobel

Christian Neefestraat 2
1077 WW Amsterdam
Netherlands

Company contact

I am interested in:

an offer
a callback
detailed information

Your request

salutation first name last name

country phone email

Please note our data protection information for the contact form.

Interview

Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.